Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor.
Teruki
T
Dainichi
Maya
M
Tanaka
Nobuko
N
Tsuruta
Masutaka
M
Furue
Keishi
K
Noda
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003131:Combined Modality Therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D005500:Follow-Up Studies; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D010304:Paronychia / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index
D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib